ABEONA THERAPEUTICS INC ABEONA (0H7R.L) Financials
0H7R.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 66.1 million | 44.0 million |
2023-06-30 | 53.6 million | 44.2 million |
2023-03-31 | 53.3 million | 34.6 million |
2022-12-31 | 64.2 million | 37.5 million |
0H7R.L Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -5.8 million | 1.6 million |
2023-06-30 | -10.3 million | 927000 |
2023-03-31 | -12.0 million | 770000 |
2022-12-31 | -14.0 million | 833000 |
0H7R.L Net Income
No data available :(
0H7R.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 54.1 million | - | - |
2023-06-30 | 37.1 million | - | - |
2023-03-31 | 40.7 million | - | - |
2022-12-31 | 52.5 million | - | - |
0H7R.L Shares Outstanding
0H7R.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 44000 | 7.1 million | 4.2 million | 720999 |
2023-06-30 | 32000 | 8.5 million | 5.0 million | 737000 |
2023-03-31 | 218000 | 8.0 million | 4.0 million | 888000 |
2022-12-31 | 25000 | 6.3 million | 5.7 million | 909000 |
0H7R.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 751000 |
2023-06-30 | 3.5 million | 838000 |
2023-03-31 | - | 888000 |
2022-12-31 | 68000 | 1.0 million |
0H7R.L
Price: $4.50
52 week price:
Earnings Per Share: -0.81 USD
P/E Ratio: -7.69
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 1.2 million